Here’s a quick rundown of the process: Visit the official Python website. Navigate to the ‘Downloads’ section. Select your ...
A collection of mini-labs I worked on during my studies, exploring different Python programming concepts. Each exercise tackles a different challenge - from basic OOP to implementing a calculator REPL ...
This project works with the OpenAI GPT-3.5 Turbo Large Language Model (LLM). However, you can also use other OpenAI models that have been trained to handle function calls. You need an OpenAI API key ...
On July 22, 2025, Replimune revealed that the FDA had issued a Complete Response Letter (CRL) for its Biologics License Application for RP1, a novel immunotherapy aimed at treating advanced melanoma.
They look, move and even smell like the kind of furry Everglades marsh rabbit a Burmese python would love to eat. But these bunnies are robots meant to lure the giant invasive snakes out of their ...
We list the best IDE for Python, to make it simple and easy for programmers to manage their Python code with a selection of specialist tools. An Integrated Development Environment (IDE) allows you to ...
A class action lawsuit was filed against Replimune Group (REPL) by Levi & Korsinsky on July 24, 2025. The plaintiffs (shareholders) alleged that they bought REPL stock at artificially inflated prices ...
NEW YORK - September 3, 2025 (NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks ...
WOBURN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...
Get the annual and quarterly balance sheet of Replimune Group, Inc. (REPL) including details of assets, liabilities and shareholders' equity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results